Alopecia areata is a tissue-restricted autoimmune disease of the hair follicle, which results in hair loss and baldness. It is often psychologically devastating. The role of T lymphocytes in this disorder was investigated with cell transfer experiments. Scalp explants from patients were transplanted to severe combined immunodeficiency (SCID) mice and injected with autologous T lymphocytes isolated from involved scalp. T lymphocytes which had been cultured with hair follicle homogenate along with antigen-presenting cells were capable of inducing the changes of alopecia areata, including hair loss and perifollicular infiltrates of T cells, along with HLA-DR and ICAM-1 expression of the follicular epithelium. Similar changes were not noted in grafts injected with scalp-derived T cells that had not been cultured with follicular homogenate. These data indicate that alopecia areata is mediated by T cells which recognize a follicular autoantigen.
Introduction
Alopecia areata is a tissue-restricted autoimmune disease directed at the hair follicle, resulting in hair loss. Patients frequently suffer severe psychiatric consequences (1) . This is especially true of girls and young women who become bald. Hair loss is associated with a primarily CD4 ϩ perifollicular lymphocytic infiltrate (2), along with expression of both DR and ICAM-1 on the follicular epithelium (3, 4) . Lesional skin from alopecia areata patients grafted onto nude mice regrows hair coincident with a loss of infiltrating lymphocytes from the graft (5) . The condition responds to immunosuppressive doses of systemic steroids. Alopecia areata has HLA-DR associations (6) , and may coexist with additional autoimmune processes such as autoimmune thyroiditis (7) . Autoreactive T cells are present in the scalp infiltrate, but are not specific for alopecia areata (8) . Circulating autoantibodies to follicular structures are present, but they are also reported in normal controls, and their role in disease pathogenesis is uncertain (9) .
This study was undertaken to clarify whether alopecia areata is mediated by T lymphocytes. Human scalp explants from involved (bald) skin were grafted onto severe combined immunodeficiency (SCID) 1 mice. Lesional (bald) scalp was used for this study, because transplantation of nonlesional, or normal scalp results in initial hair loss, whereas transplantation of bald skin results in hair regrowth. SCID mice have been used previously to transfer psoriasis to human skin explants with T cell injections (10, 11) . 40 d after transplantation, the scalp explants grew hair, and autologous lymphocytes were injected into the explants in an attempt to reproduce the disease. T lymphocytes isolated from scalp lesions, and expanded in vitro with homogenates of hair follicles, were able to reproduce the changes of alopecia areata when transferred into scalp explants. T lymphocytes not cultured with hair follicle homogenates did not have this effect. These data strongly indicate a role for T lymphocytes responding to a follicular autoantigen in the pathogenesis of alopecia areata.
Methods
Patients. Six patients (five females and one male, mean age 32 yr) with severe lesions of alopecia areata of 1-15 yr in duration were included in this study. Informed consent was obtained after the nature and possible consequences of the studies were explained. Protocols were approved by the Institutional Review Board. None of the patients had any therapy in the 60 d before obtaining the scalp biopsy specimens.
19 2-mm punch biopsies from involved areas were obtained from each patient. Four biopsies from each patient were used for the isolation of autologous cutaneous T cells. Two biopsies were snap-frozen in liquid nitrogen for immunoperoxidase staining. One frozen biopsy was sectioned vertically, and the other was sectioned horizontally. An additional biopsy from each patient was submitted for routine histological examination with hematoxylin and eosin and horizontally sectioned in its entirety. 12 punch biopsies (2-mm) were grafted in sets of three to four SCID mice. This allowed the formation of four treatment groups consisting of six mice, one from each patient.
Animals. SCID mice (Charles River Laboratories, Margate, UK), 2-3 mo old, were used in this study. The mice were raised in the pathogen-free animal facility of the B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology. Animal care and research protocols were in accordance with institutional guidelines.
Skin grafting. Graft transplantation to SCID mice was performed as described previously (4) . Each 2-mm graft was inserted through an incision in the skin into the subcutaneous tissue over the lateral thoracic cage of each mouse, and covered with a standard dressing. The dressing was removed on day 7.
Isolation of T lymphocytes from scalp punch biopsies. Four punch biopsies from each patient were used for T cell isolation. Tissue infiltrating lymphocytes were isolated from scalp punch biopsy with the use of collagenase, as described previously (12) . The number of cells retrieved from each patient averaged 500,000.
Isolation of human PBMC. PBMC were isolated from heparinized whole blood by centrifugation over Hypaque 1077 (Pharmacia Biotech AB, Uppsala, Sweden), and allowed to adhere to 24-well plates (Greiner) in RPMI 1% human AB serum for 90 min at 37 Њ C, 5% CO 2 . Nonadherent cells (6-8 ϫ 10 6 ) were removed and used for culture.
Hair follicle homogenate preparation. Anagen hair follicles were isolated under a stereodissecting microscope from normal scalp biopsies obtained from healthy subjects who underwent hair transplantation procedures. The hair follicles were mechanically homogenized in PBS using a 15-ml glass tissue grinder (Lawson Mardon Wheaton, Milville, NJ), centrifuged at 500 g for 30 min, and sterilized by millipore filtration (0.22 m; Gelman Sciences, Inc., Ann Arbor, MI). The protein content of each homogenate was assayed by a colorimetric assay (13) . The samples were stored at Ϫ 20 Њ C and diluted with culture medium to a final protein concentration of 10 g/ml.
Culture of T lymphocytes. Lymphocytes were plated at 10 5 cells/ well in RPMI-FCS, along with irradiated (5000R) PBMC (10 5 cells/ well) in 24-plate wells (Greiner Labortecnik, Frichenhausen, Germany), as feeders. After 3 d of culture, rIL-2 (10 U/ml; Genzyme Corp., Cambridge, MA) was added. Every 5 d, the T cells were restimulated with feeders, for a total of five cycles over 5 wk.
Lymphocytes were stimulated with follicular homogenate preparations by a modification of the above protocol, in which follicular homogenate (10 g/ml) was added along with the feeder cells at each stimulation.
Phenotypic characterization of cultured T lymphocytes. Phenotype of the cultured of T cell lines was determined by cytofluorograph analysis (FACScalibur ® ; Becton Dickinson, Mountain View, CA). The following mAbs were used: anti-CD3 FITC (clone SK 7; Becton Dickinson), anti-CD4 (IgG2a, S3.5), anti-CD8 (IgG2a, 3B5) (Caltag Labs, South San Francisco, CA), anti-HLA-DR (IgG2a, DK22; DAKO A/S, Glostrup, Denmark). Subtype-matched mouse IgG-FITC (Becton Dickinson) was used as a negative control.
Injection of cultured T lymphocytes into grafts on SCID mice. The SCID mice bearing grafts of lesional scalp were divided into four groups of six mice each. On day 40 the grafts were injected intradermally with autologous lymphocytes as noted below. The first group received intradermal injections of autologous PBMC into the scalp grafts. Each graft received 1.6 ϫ 10 6 cells in 0.2 ml RPMI 1640. The grafts of the second group were injected intradermally with 1.3 ϫ 10 6 autologous T cells (in 0.2 ml RPMI 1640) isolated from lesional scalp (scalp T cells). Before injections the T cells were cultured with hair follicle homogenates as an antigen. The third group was also injected intradermally with autologous T cells of lesional scalp but not cultured with homogenates. These grafts received the same number of cells as were injected into the second group (1.3 ϫ 10 6 cells). The fourth group served as a control, and was not injected with T cells, in order to observe a possible effect of the residual human T cells within the grafts. On day 82, the mice were killed and grafts were harvested for immunohistochemical and histological analysis.
Immunohistochemical staining. Staining was performed as reported previously (14) . mAbs to human antigens used were as follows: anti-HLA-DR, anti-CD54 (ICAM-1) (Biodesign International, Kennebunk, ME), anti-CD3, anti-CD4, anti-CD8, anti-CD25 (DAKO A/S), and anti-HLA-class 1 (DAKO A/S). Each specimen was coded at the time of biopsy and evaluated by two observers who were blind to the coding.
Statistical analysis. Statistical analysis was carried out using ANOVA and the Tukey-Kramer multiple comparisons test.
Results
T cells were cultured from scalp biopsies of alopecia areata patients with the use of irradiated autologous PBMC and hair follicle homogenate, as described above. Flow cytometric analysis of the scalp T cells before injections revealed the following phenotype: CD3 ϩ 98%, CD4 ϩ 55.7%, CD8 ϩ 84.5%, and HLA-DR ϩ 84.5%. This reflects the presence of double-positive CD4 ϩ CD8 ϩ cells. Double-positive CD4 ϩ CD8 ϩ cells are commonly found after culture of skin infiltrating cells (12) . A similar T cell phenotype was found for scalp TC-homogenate (scalp TC-Hom) and scalp T cells, with the exception that the percentage of HLA-DR ϩ was 19% for T cells cultured without homogenate (Table I) . There was also a significantly higher recovery of T cells from cultures with hair follicle homogenate relative to scalp T cell cultures without homogenate (Table I , P Ͻ 0.001 by ANOVA). The increases in T cell recovery and HLA-DR expression indicate activation and proliferation of the scalp T cells by follicular homogenate. The analysis of cultured PBMC before injections revealed the following phenotype: CD3 ϩ 99%, CD4 ϩ 15.6%, CD8 ϩ 64.8%, and HLA-DR ϩ 48.8%. All T cells had been cultured under identical conditions before injection, with the exception that scalp TC-Hom also received follicular homogenate.
The biopsies obtained from lesional scalp before grafting were characteristic of alopecia areata. No terminal hairs were observed, and some follicles were observed to be in the anagen phase. Perifollicular mononuclear cell infiltrates were associated with 48% of hair follicles. The perifollicular infiltrates were composed of both CD4 ϩ and CD8 ϩ T cells, with a relative predominance of CD4 ϩ over CD8 ϩ cells. CD4 ϩ cells were found around the hair follicles. In contrast, intrafollicular infiltrates were composed mostly of CD8 ϩ cells, with only a few CD4 ϩ cells detected. IL-2 receptor (CD25) expression was detected among the cells of both the peri-and intrafollicular infiltrates. HLA-DR and ICAM-1 were expressed by 18 and 36% of the follicles before grafting (Table II) .
The number of hairs in each graft was determined under magnification ( ϫ 5) twice weekly. By day 40, when lymphocytes were injected, hair was present in 38% of the grafts. Hair growth increased in all treatment groups up to 68 d (Fig. 1) . By day 82, hair was present in 83% of noninjected control grafts (Fig. 1) . Similar continual increases in hair growth were observed in grafts injected with PBMC, as well as scalp T cells. In contrast, scalp grafts injected with scalp T cells which had been incubated with hair follicle homogenate lost hair after 68 d (Fig. 1) . Thus, scalp TC-Hom induced hair loss. Injection of these T cells also reduced the number of hairs per graft (Fig.  1) . The number of hairs per graft on days 75 and 82 was significantly (ANOVA, P Ͻ 0.05) lower in grafts injected with scalp TC-Hom than in the remaining groups. Grafts injected with scalp TC-Hom also had a significant reduction in hairs per graft on day 82 relative to day 68 (ANOVA, P Ͻ 0.05).
Grafts treated with scalp TC-Hom had histologic evidence of alopecia areata (Fig. 2) , including a dense infiltrate of mononuclear cells, as well as follicular dystrophy, with matrix and hair bulb degeneration. Few anagen follicles were present only at higher levels of the dermis, and no terminal hairs were noted. In contrast, grafts injected with PBMC, or scalp T cells (no homogenate), revealed normal terminal hairs without follicular damage (Fig. 2) .
The infiltrates of grafts injected with scalp TC-Hom were composed of both CD4 ϩ and CD8 ϩ cells. CD4 ϩ cells were primarily perifollicular, whereas CD8 ϩ cells were intrafollicular. In contrast, grafts injected with PBMC or scalp T cells (cultured without homogenate) exhibited rare CD8 ϩ cells and moderate perifollicular infiltrates in only 24-27% of hair follicles.
Foci of CD25 ϩ cells were detected in the upper dermis as well as around and within 11 out of 42 (26%) hair follicles of grafts treated with scalp TC-Hom. PBMC and scalp T cellinjected grafts had foci of CD25 ϩ cells in the upper dermis only.
HLA-DR and ICAM-1 expression was induced by injection of scalp TC-Hom (Table II and Figs. 3 and 4) . Similar induction of HLA-DR and ICAM-1 expression was not observed with injection of scalp T cells not incubated with hair follicle homogenate.
Discussion
These data strongly support a role for T cells in the pathogenesis of alopecia areata. In these experiments, we first caused a remission of alopecia areata, and then induced a recurrence. Since alopecia areata is naturally a remitting, recurring condition this model mimics the natural pathology of the disease. Alopecia areata was reproduced in grafts injected with autologous T cells that had been isolated from patient scalps and cultured with hair follicle homogenates. Characteristics of alopecia areata which were reproduced included hair loss, a dense perifollicular T cell infiltrate, and expression of HLA-DR, and ICAM-1 by follicular epithelium. Grafts injected with PBMC, or scalp T cells that had not been cultured with hair follicle homogenate, did not induce these changes. The requirement for follicular homogenate in the activation of the pathogenic T cells suggests that T cell recognition of follicular autoantigen is central to the pathogenesis of alopecia areata.
The follicular homogenate was obtained from normal scalp and washed out before injection of the T cells. It is proposed that the action of the follicular homogenate was to selectively expand autoantigen reactive T cells. The inability of the scalp T cells to produce pathology in the absence of follicular homogenate may reflect a low frequency of autoreactive T cells in the absence of antigen-specific stimulation.
It was necessary to use lesional (bald) scalp for the explants because transplantation of noninvolved scalp, or scalp from normal donors results in loss of hair without regrowth (15) . For this reason, it was not possible to perform these experiments with noninvolved or normal scalp explants. Previously, we demonstrated normal hair growth in scalp biopsies of patients with alopecia areata transplanted onto nude mice (5), indicating that hair follicles of alopecia areata have growth potential. The experiments were designed so that T lymphocytes were always injected into autologous scalp explants, thereby ensuring MHC compatibility.
The ability of injected T cells to induce alopecia areata was not a nonspecific effect of activated T cells, since it was not produced by the injection of IL-2-activated T cells isolated from peripheral blood or scalp. Prior experiments have demonstrated that lesional scalp T cells activated with PHA were not capable of inducing alopecia areata, indicating this is not a nonspecific effect of activated T lymphocytes (data not shown). The role for T cells in alopecia areata is supported by the failure of administration of patients' serum to inhibit hair growth in the nude mouse model (16) .
In common with a number of tissue-restricted autoimmune disorders, lesional hair follicles in alopecia areata show ectopic HLA-DR and ICAM-1 molecules (17) . These markers are known to be important in antigen presentation and lymphocyte trafficking and can be modulated by the action of cytokines including IFN-␥ .
Elevated HLA class I expression in follicular epithelium is associated with CD8 ϩ intrafollicular infiltrates (18) . This may reflect CD8 ϩ cell recognition of hair follicle autoantigens pre- sented by HLA class I (19, 20) . Dense perifollicular infiltrates of CD4 ϩ cells were also noted in association with dystrophic follicles. Autoreactive CD4 ϩ cells, which recognize autologous monocytes, are found in the infiltrate of alopecia areata and are proposed to have a secondary role in amplification of the pathology (8) .
T cells isolated from scalps of patients with alopecia areata and cultured with hair follicle homogenates induced both hair loss and the pathologic findings of alopecia areata when injected into autologous scalp grafted onto SCID mice. These data indicate that alopecia areata is a tissue-restricted autoimmune disease, mediated by a T lymphocyte response to a follicular autoantigen. 
